Analyst Reco. Repare Therapeutics Inc.

Equities

RPTX

US7602731025

Market Closed - Nasdaq Other stock markets 01:30:00 28/06/2024 am IST			5-day change	1st Jan Change
3.38 ^USD	+0.30%		-3.98%	-53.70%

26/06	Repare Therapeutics Says Lunresertib With Folfiri Shows 'Promising' Efficacy, Tolerability in Phase 1 Solid Tumor Study	MT
26/06	Repare Therapeutics Inc. Announces Positive Initial Data at ESMO GI from Phase 1 MINOTAUR Trial Evaluating Lunresertib in Combination with FOLFIRI	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Repare Therapeutics Price Target to $10 From $25, Maintains Buy Rating	14/02	MT
Piper Sandler Cuts Repare Therapeutics' Price Target to $25 From $30, Keeps Overweight Rating	16/23/16	MT
Stifel Raises Repare Therapeutics' Price Target to $17 From $16, Keeps Buy Rating	25/23/25	MT
HC Wainwright Adjusts Price Target on Repare Therapeutics to $25 From $26, Keeps Buy Rating	17/23/17	MT
Stifel Upgrades Repare Therapeutics to Buy From Hold, Adjusts Price Target to $16 From $11	09/23/09	MT
HC Wainwright Adjusts Repare Therapeutics Price Target to $26 From $25, Maintains Buy Rating	09/23/09	MT
Morgan Stanley Adjusts Price Target on Repare Therapeutics to $14 From $15, Maintains Equal-Weight Rating	27/23/27	MT
Morgan Stanley Downgrades Repare Therapeutics to Equal Weight From Overweight, Adjusts Price Target to $15 From $28	03/23/03	MT
HC Wainwright Adjusts Repare Therapeutics' Price Target to $25 From $38, Keeps Buy Rating	17/22/17	MT
Morgan Stanley Adjusts Price Target on Repare Therapeutics to $28 From $30, Maintains Overweight Rating	08/22/08	MT
Berenberg Bank Adjusts Repare Therapeutics' Price Target to $31 From $34, Maintains Buy Rating	08/22/08	MT
Goldman Sachs Adjusts Price Target for Repare Therapeutics to $29 From $30, Maintains Buy Rating	05/22/05	MT
HC Wainwright Adjusts Repare Therapeutics' Price Target to $38 From $54, Keeps Buy Rating	06/22/06	MT
Piper Sandler Adjusts Repare Therapeutics' Price Target to $30 From $25, Keeps Overweight Rating	02/22/02	MT
Berenberg Bank USA Conference	23/22/23	FA
Berenberg Bank Adjusts Repare Therapeutics' Price Target to $34 From $51, Maintains Buy Rating	12/22/12	MT
Stifel Nicolaus Downgrades Repare Therapeutics to Hold From Buy, Adjusts Price Target to $11 From $45	12/22/12	MT
Piper Sandler Adjusts Price Target on Repare Therapeutics to $25 From $40, Reiterates Overweight Rating	12/22/12	MT
Northland Adjusts Repare Therapeutics' Price Target to $45 From $40, Keeps Outperform Rating	18/21/18	MT
REPARE THERAPEUTICS : Stifel Starts Repare Therapeutics at Buy With $48 Price Target	23/21/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Repare Therapeutics Inc.

Equities

RPTX

US7602731025

Analyst Reco.

Filters